- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 54.65M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 54.65M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 53.96M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$233.76K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$977.41K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $199.63K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $216.95K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.23M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $927.47K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.1M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.24M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $7.85M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $8.17M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.25M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.44M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.01M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.34M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $9.78M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $16.78M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.11M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $19.58M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.77M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $3.66M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.84M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$430.44K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $350.69K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $260.46K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $3.12M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $3.92M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $9.05M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $11.11M |
| Revenue | Q1 2026 · Mar 31, 2026 | $12.18M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $15.03M |